课题基金 / 基金详情

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN POST RENAL TRANSPLANTED CHILDREN

RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN POST RENAL TRANSPLANTED CHILDREN
肾移植后儿童的重组人类生长激素（NUTROPIN）
批准号：
6118420
负责人：
ROBERT Bruce ETTENGER
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6118420
关键词：
body height child physical development clinical research drug screening /evaluation homologous transplantation human subject kidney transplantation pediatric pharmacology postoperative state recombinant proteins somatotropin transplant rejection

项目摘要

项目成果

ROBERT Bruce ETTENGER的其他基金

相关文献

中文摘要
翻译
本研究的具体目的是：1）确定使用Nutropin治疗生长迟缓的肾移植受者是否会加速生长速度和改善标准身高（SDS）; 2）确定使用Nutropin治疗儿童肾移植患者是否会导致急性移植物功能障碍或慢性排斥反应的发生或进展，通过移植物的显著变化来衡量。功能
英文摘要
The specific aims of this study are to 1) determine if treatment of growth retarded renal transplant recipients treated with Nutropin will have acceleration of growth velocity and improvement in standardized height (SDS) and 2) determine if treatment of pediatric renal transplant patients with Nutropin will result in the development or progression of accute allograft dysfunction or chronic rejection as measured by a significant change in allograft function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
PHASE I/II OPEN-LABEL PHARMACOKINETIC AND SAFETY STUDY OF ZENAPAX